|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-4-27
|
|
pubmed:abstractText |
Warfarin sodium is highly effective for prevention of embolic stroke, particularly in nonvalvular atrial fibrillation, but its expected benefit can be offset by risk of intracerebral hemorrhage (ICH). We studied the determinants of ICH outcome to quantify the independent effect of warfarin.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
164
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
880-4
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15111374-Aged,
pubmed-meshheading:15111374-Anticoagulants,
pubmed-meshheading:15111374-Cerebral Hemorrhage,
pubmed-meshheading:15111374-Dose-Response Relationship, Drug,
pubmed-meshheading:15111374-Female,
pubmed-meshheading:15111374-Humans,
pubmed-meshheading:15111374-International Normalized Ratio,
pubmed-meshheading:15111374-Logistic Models,
pubmed-meshheading:15111374-Male,
pubmed-meshheading:15111374-Middle Aged,
pubmed-meshheading:15111374-Multivariate Analysis,
pubmed-meshheading:15111374-Warfarin
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.
|
|
pubmed:affiliation |
Neurology Clinical Trials Unit, Department of Neurology, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
